These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 17541852)

  • 41. Disinhibition of libido: an adverse effect of SSRI?
    Greil W; Horvath A; Sassim N; Erazo N; Grohmann R
    J Affect Disord; 2001 Feb; 62(3):225-8. PubMed ID: 11223111
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Severe sleepiness and excess sleep duration induced by paroxetine treatment is a beneficial pharmacological effect, not an adverse reaction.
    Murata Y; Kamishioiri Y; Tanaka K; Sugimoto H; Sakamoto S; Kobayashi D; Mine K
    J Affect Disord; 2013 Sep; 150(3):1209-12. PubMed ID: 23809402
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A prospective study of 86 new patients with social anxiety disorder.
    Allgulander C; Nilsson B
    Acta Psychiatr Scand; 2001 Jun; 103(6):447-52. PubMed ID: 11401659
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Successful treatment of sexual dysfunction with dronabinol: a case report.
    Salerian AJ
    J Clin Psychiatry; 2004 Aug; 65(8):1146-7. PubMed ID: 15323605
    [No Abstract]   [Full Text] [Related]  

  • 45. By the way, doctor. I've been taking Paxil for depression for about six months. Although it's helped my symptoms of depression, I've lost interest in sex. Aside from stopping the medication, is there any way to regain my sexual function?
    Robb-Nicholson C
    Harv Womens Health Watch; 2001 Feb; 8(6):7. PubMed ID: 11175469
    [No Abstract]   [Full Text] [Related]  

  • 46. A review of the psychomotor effects of paroxetine.
    Hawley CJ; McPhee S; Quick SJ; Smith VR
    Int Clin Psychopharmacol; 1997 Jan; 12(1):13-8. PubMed ID: 9179629
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Precision dosing-based optimisation of paroxetine during pregnancy for poor and ultrarapid CYP2D6 metabolisers: a virtual clinical trial pharmacokinetics study.
    Almurjan A; Macfarlane H; Badhan RKS
    J Pharm Pharmacol; 2020 Aug; 72(8):1049-1060. PubMed ID: 32346890
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Paroxetine-Related Adult-Onset Tic Disorder: A Presentation of Primary Progressive Multiple Sclerosis.
    Mendonça MD; Leitão C; Barahona-Corrêa B; Lampreia T
    J Neuropsychiatry Clin Neurosci; 2015; 27(3):e214-5. PubMed ID: 26222974
    [No Abstract]   [Full Text] [Related]  

  • 49. Hyperglycemia associated with paroxetine.
    Petty KJ
    Ann Intern Med; 1996 Nov; 125(9):782. PubMed ID: 8929027
    [No Abstract]   [Full Text] [Related]  

  • 50. Severe adverse effects in a newborn with two defective CYP2D6 alleles after exposure to paroxetine during late pregnancy.
    Laine K; Kytölä J; Bertilsson L
    Ther Drug Monit; 2004 Dec; 26(6):685-7. PubMed ID: 15570195
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Very long half-life of paroxetine following intoxication in an extensive cytochrome P4502D6 metabolizer.
    Hilleret H; Voirol P; Bovier P; Giannakopoulos P; Zullino D; Baumann P; Giroud C; Rivier L; Eap CB
    Ther Drug Monit; 2002 Aug; 24(4):567-9. PubMed ID: 12142644
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Adjunctive Donepezil for Anxiety Symptoms With Poor Response to Paroxetine in a Patient With Probable Mild Cognitive Impairment.
    Chu CW; Liang CS; Wan FJ
    Clin Neuropharmacol; 2018; 41(6):236-237. PubMed ID: 30273190
    [No Abstract]   [Full Text] [Related]  

  • 53. Treatment of drug-induced anorgasmia.
    Segraves RT
    Br J Psychiatry; 1994 Oct; 165(4):554. PubMed ID: 7804679
    [No Abstract]   [Full Text] [Related]  

  • 54. Dr Preskorn replies.
    Preskorn SH
    J Clin Psychiatry; 2013 Oct; 74(10):1025-6. PubMed ID: 24229758
    [No Abstract]   [Full Text] [Related]  

  • 55. Complete loss of libido with short-term use of lorazepam.
    Khandelwal SK
    Am J Psychiatry; 1988 Oct; 145(10):1313-4. PubMed ID: 3421355
    [No Abstract]   [Full Text] [Related]  

  • 56. Oxytocin and sexual function in males and females with schizophrenia.
    Wehring HJ; Buchanan RW; Feldman S; Carpenter WT; McMahon RP; Weiner E; Gold JM; Adams HA; Strauss GP; Rubin LH; Kelly DL
    Schizophr Res; 2018 Sep; 199():431-432. PubMed ID: 29551232
    [No Abstract]   [Full Text] [Related]  

  • 57. Paroxetine may cause increase in carcinoebmryonic antigen (CEA).
    Ceylan ME; Turkcan A; Ozer U
    Eur J Clin Pharmacol; 2009 Dec; 65(12):1271. PubMed ID: 19688204
    [No Abstract]   [Full Text] [Related]  

  • 58. Value of Supportive Care Pharmacogenomics in Oncology Practice.
    Patel JN; Wiebe LA; Dunnenberger HM; McLeod HL
    Oncologist; 2018 Aug; 23(8):956-964. PubMed ID: 29622698
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The impact of severe mental disorders and psychotropic medications on sexual health and its implications for clinical management.
    Montejo AL; Montejo L; Baldwin DS
    World Psychiatry; 2018 Feb; 17(1):3-11. PubMed ID: 29352532
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Delayed Ejaculation: Pathophysiology, Diagnosis, and Treatment.
    Abdel-Hamid IA; Ali OI
    World J Mens Health; 2018 Jan; 36(1):22-40. PubMed ID: 29299903
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.